These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 27064684

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in 18 F-FDG PET imaging.
    Wu L, Liu FT, Ge JJ, Zhao J, Tang YL, Yu WB, Yu H, Anderson T, Zuo CT, Chen L, Wang J.
    Hum Brain Mapp; 2018 Dec; 39(12):4652-4662. PubMed ID: 29999569
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment.
    Gasca-Salas C, Clavero P, García-García D, Obeso JA, Rodríguez-Oroz MC.
    Hum Brain Mapp; 2016 Mar; 37(3):968-77. PubMed ID: 26663702
    [Abstract] [Full Text] [Related]

  • 6. Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism.
    Pappatà S, Santangelo G, Aarsland D, Vicidomini C, Longo K, Bronnick K, Amboni M, Erro R, Vitale C, Caprio MG, Pellecchia MT, Brunetti A, De Michele G, Salvatore M, Barone P.
    Neurology; 2011 Oct 04; 77(14):1357-62. PubMed ID: 21940621
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Statistical parametric mapping analysis of 18F-FDG PET in Parkinson's disease with mild cognitive impairment].
    Chu JS, Liu TH, Zang YZ, Wang KL, Ma HZ, Han CL, Zhao XB, Liu YP, Xia XT, Meng FG.
    Zhonghua Yi Xue Za Zhi; 2018 Sep 04; 98(33):2632-2635. PubMed ID: 30220149
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y, Nie K, Huang B, Mei M, Guo M, Xie S, Huang Z, Wang L, Zhao J, Zhang Y, Wang L.
    Neurosci Lett; 2017 Sep 29; 658():121-132. PubMed ID: 28823894
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson's disease with mild cognitive impairment.
    Kim H, Oh M, Oh JS, Moon H, Chung SJ, Lee CS, Kim JS.
    Nucl Med Commun; 2019 Dec 29; 40(12):1216-1223. PubMed ID: 31584466
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET.
    Berding G, Odin P, Brooks DJ, Nikkhah G, Matthies C, Peschel T, Shing M, Kolbe H, van Den Hoff J, Fricke H, Dengler R, Samii M, Knapp WH.
    Mov Disord; 2001 Nov 29; 16(6):1014-22. PubMed ID: 11748732
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.